| Number | Percentage | HMGB1high [n (%)] |
---|---|---|---|
Patients | 40 | Â | 32 (80) |
Gender | |||
 Male | 28 | 70 | 23 (57.5) |
 Female | 12 | 30 | 9 (22.5) |
Age | |||
 Median | 56 |  |  |
 Range | 34–75 |  |  |
 ≤ 50 y | 16 | 40 | 11 (27.5) |
 >50 y | 24 | 60 | 21 (52.5) |
TNM stage | |||
 Stage I | 3 | 7.5 | 1 (2.5) |
 Stage II | 14 | 35 | 7 (17.5) |
 Stage III | 17 | 42.5 | 16 (40) |
 Stage IV | 6 | 15 | 6 (15) |
Lymph nodes | |||
 Positive | 9 | 22.5 | 8 (20) |
 Negative | 31 | 77.5 | 6 (15) |
Distance metastasis | |||
 Positive | 6 | 15 | 6 (15) |
 Negative | 34 | 85 | 8 (22.5) |
Response to therapy | |||
 Partial response + stable disease | 6 | 15 | 2 (5) |
 Progressive disease | 29 | 72.5 | 25 (62.5) |
 Not assessed | 5 | 12.5 |  |